Catalyst Wire Dossier Catalyst Wire Dossier

HEC53856

· Sunshine Lake Pharma Co., Ltd.
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for HEC53856, covering 2025-05-15 to 2025-05-15. Get the full timeline:

Most recent: Clinical Trial Update: HEC53856 Phase Ib Study in Patients With Non-dialysis Renal Anemia [Phase 1]

See pricing